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Involvement of Cyclic GMP Phosphodiesterase Activator in an Hereditary Retinal
Degeneration
Abstract
CYCLIC NUCLEOTIDES mediate many aspects of normal cellular metabolism; thus, degradation as well as
synthesis of these intracellular mediators must be strictly regulated. Phosphodiesterase (PDE), the
enzyme of cyclic nucleotide catabolism, is present in mammalian tissues in multiple forms, which differ in
substrate specificity, kinetic characteristics and sub-cellular localisation. Moreover, a calcium-dependent
protein activator (now called calmodulin) has been characterised that specifically activates at least one of
the PDE types although other types of PDE are known to be activator independent. Thus, several
mechanisms are present in vivo which allow strict control of PDE. A unique cyclic GMP-PDE is
compartmentalised in the outer segments of retinal photoreceptor cells; its activity is low in the darkadapted state but increases dramatically on light adaptation. The resulting drop in cyclic GMP content
could serve as a chemical ‘signal’ in the normal visual process. However, despite much investigation of
various cyclic nucleotide systems, no definitive information has been obtained which clearly links a
disorder of cyclic nucleotide metabolism with a disease process elsewhere than in retina. We have
recently presented preliminary evidence that an abnormality in cyclic GMP metabolism could be present
in the retinas of Irish setter dogs with inherited rod–cone dysplasia that could lead to greatly increased
cyclic GMP content, as had been reported in mice with inherited retinal degeneration. We now report that
the basic defect in the disease seems to be a failure to switch PDE type and a concomitant decrease in
protein activator concentration early in postnatal development, at the time of photoreceptor
differentiation.
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the mean distance between gap junctions linking neighbouring
L 1 units should be greater in the direction parallel to the streak
than perpendicular to it. Assuming that cytoplasmic resistance is
much lower than junctional resistance, the signal attenuation
will occur mainly at these junctions. We further assume a
uniform distribution of gap junctions along the cell surface. The
signal attenuation per unit length normal to the slit stimulus will
then be greater in the direction perpendicular to the streak
resulting in receptive fields elongated along the streak.
The mechanism described above is based upon a network of
L 1 units each of which has a common orientation. A random
distribution of orientations of elongated cells would result in
more equal mean distances between junctions along any two
orthogonal directions. This type of anatomical arrangement is in
fact seen in Golgi-impregnated L 1 -type horizontal cells in the
peripheral retina. Here, our preliminary physiological findings
indicate that L 1 -type horizontal cells have response eccentricities closer to 1.0 with no consistently observed preferred
orientation along any particular axis.
In this paper, we have shown that the streak region of t~e
turtle retina contains at least one population of cells wtth
specialised properties; the axonal arborisations and the receptive fields of L 1 horizontal cells in this region are elongated in the
direction of the streak. The functional significance of the specialisations in the streak region may be better understood from
ganglion cell recordings in this region. However, such
measurements have only been made in the visual streak of
another species, the rabbit 1 • Amongst rabbit ganglion cells in
this region, orientation selective units were found which
responded only to slits of light which were oriented either
parallel or perpendicular to the streak. _Although a full u?derstanding of receptive fields at the ganglion cell level requues a
greater knowledge of signal processing in the inner and outer
plexiform layers, the oriented horizontal cell receptive fields
described here may have significance for the development of
orientation specificity in the visual streaks of species whose
retinas contain this specialisation.
We thank Walter Stewart for Lucifer dye, and E. I. DuPont
deNemours & Co. (Inc.) for the Pontamine Fast Turquoise. We
thank Drs K. I. Naka and J. Schnapf for reading the manuscript
and Dr R. Nelson for useful discussions.

Involvement of cyclic GMP
phosphodiesterase activator
in an hereditary retinal degeneration
CYCLIC NUCLEOTIDES mediate many aspects of normal cellular metabolism 1 ; thus, degradation as well as synthesis of these
intracellular mediators must be strictly regulated. Phosphodiesterase (PDE), the enzyme of cyclic nucleotide catabolism,
is present in mammalian tissues in multiple forms, which
differ in substrate specificity, kinetic characteristics and subcellular localisation 2 • Moreover, a calcium-dependent protein
activator (now called calmodulin) has been characterised that
specifically activates at least one of the PDE types 3 ' 4 although
other types of PDE are known to be activator independent5 "6 •
Thus, several mechanisms are present in vivo which allow strict
control of PDE. A unique cyclic GMP-PDE is compartmentalised in the outer segments of retinal photoreceptor
cells7 - 10 ; its activity is low in the dark-adapted state but increases
dramatically on light adaptation 10- 12 • The resulting drop in cyclic
GMP content could serve as a chemical 'signal' in the normal
visual process 13 •14 • However, despite much investigation of
various cyclic nucleotide systems, no definitive information has
been obtained which clearly links a disorder of cyclic nucleotide
metabolism with a disease process elsewhere than in retina 15 "16 •
We have recently presented preliminary evidence that an
abnormality in cyclic GMP metabolism could be present in the
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Fig. I a, Photoreceptor layer from a 13-d-old normal Irish sette.r.
Photoreceptor outer segments have begun to elongate and contam
well organised stacks of outer segment (OS) lamellar disks. Some of
these seem to have been engulfed (arrow) by the pigment epithelium (PE). b, Photoreceptor layer from a 13-d old affected Irish
setter. Small photoreceptor inner segments (IS) project through
the external limiting membrane (ELM). There is minimal outer
segment material; some is apposed to the PE apex (arrow) and
some seems to be located within the PE cytoplasm (double arrow)
xl0,400.
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Fla. 3 Schematic outline of morphological and biochemical
events in the development of outer segments (OS) in control and
affected retinas. In both control and affected retinas, no OS are
observed in the first postnatal week. OS appear in the second week,
develop normally (4-5 weeks) in the control retinas but quickly
degenerate in affected retinas. Biochemically, the cyclic GMPPDE enzyme switches from an activator-dependent to an activator-independent type in control retinas but not in affected retinas.
Protein activator concentration is substantially decreased in
affected retinas.

It is well known that enzyme patterns change during
developmene 3 •24 • Recent evidence suggests that, at least in
some tissues, PDE activity changes during differentiation with
regard to its sensitivity to regulation by the Ca 2 +-dependent
protein activator25 ' 26 • Our data strongly indicate that a normal
switch in PDE type fails to occur in affected retinas during
photoreceptor development and that the low level of activator
present in these retinas may not be sufficient to maintain
adequate cyclic GMP-PDE activity (Fig. 3).1t seems, therefore,
that for the first time calmodulin can be directly linked to a
disease process. It will be interesting to see if a similar situation
exists in other degenerative diseases or if this biochemical defect
is unique to inherited degeneration of the neural retina.
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National Retinitis Pigmentosa Foundation.
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Evidence that cyclic GMP
regulates membrane
potential in rod photoreceptors
have been proposed as mediators of
the decreased Na+ permeability caused by illumination of
vertebrate photoreceptors 1•2 • We show here that cyclic GMP
depolarises the rod outer segment (ROS) approximately to the
Na+ equilibrium potential within milliseconds after being
injected intracellularly, that previous light adaptation
antagonises this depolarisation, and that the injection of cyclic
GMP without illumination initiates a repolarisation after a time
lag which is longer than that following a light flash and proportional to the injection time. The results are interpreted in terms
of a model in which cyclic GMP levels are controlled by the
resultant of cyclase and phosphodiesterase (PDE) velocities.
The PDE velocity of hydrolysis in the dark is increased by prior
light adaptation in the presence of increased substrate (cyclic
GMP). The data suggest that cyclic GMP is an important factor
in the regulation of the membrane potential of the ROS.
Biochemical experiments on the cyclic nucleotide system of
isolated homogenised ROS suggest that illumination decreases
the concentration of cyclic GMP by activating a GTP-dependent
PDE3.4. The rate of light-initiated hydrolysis of cyclic GMP by
PDE is apparently sufficiently fast to mediate the rapid initial
decrease in Na+ permeabilty5 •6 • The cyclic GMP that is not
hydrolysed presumably increases Na+ permeability. The
mechanism of increased Na+ permeability of the ROS plasma
membrane would be by phosphorylating a membrane protein 6 •7
as proposed for other tissues. Superfusion with cyclic GMP or a
PDE inhibitor has been shown to depolarise rods 8 • We have
injected cyclic GMP intracellularly through the recording
pipette into ROS of the isolated retina of the toad, Bufo
marinus, to determine the effects of excess cyclic GMP on
membrane potential, latency and amplitude of the light
response. We reported9 that this excess cyclic GMP increases
both the latency and amplitude of the response. Here, using the
same preparation and methods, we found that excess injected
cyclic GMP depolarised the rod membrane. This depolarisation
in dark -adapted preparations frequently exceeded the zero level
(Figs 1, 2) and attained a maximum value of + 11 mV (Fig. 1a,
d). A reversal potential of 0 to + 10 mV was obtained for the
isolated Necturus rod 10 • A value of + 11 m V implies an intracellular Na+ concentration ([Na+),) of 66 mM, based on our
extracellular concentration of 103 mM. This compares with
50 mM [Na+), estimated using another techniqueu. Therefore,
+ 11 mV seems to approximate to the equilibrium potential for
Na+. The maximum depolarisation we observe is consistent with
the interpretation that the injected excess cyclic GMP renders
the ROS plasma membrane permeable to Na+.
Intracellular injection of cyclic GMP in the absence of illumination should initiate a recovery from depolarisation after a
time proportional to the amount injected, provided the dark
concentration is less than the Km of PDE which is 70 ~tM cyclic
CYCLIC NUCLEOTIDES
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